Cardioprotection for 20 Years for Children With Cancer
A case is building for the routine use of dexrazoxane to protect the hearts of children with cancer being treated with doxorubicin.
Source: medscape.com
Page 3 - Rocket Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Rocket Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Rocket Pharma Today - Breaking & Trending Today
Anjarium Biosciences Appoints Gaurav Shah as Chairperson and Douglas Fambrough as Non-executive Director
Board expansion brings significant additional gene therapy and corporate development expertise to AnjariumZURICH, Oct. 18, 2022 /PRNewswire/ -- Anjarium Biosciences AG ("Anjarium"), a biotech
Source: finanznachrichten.de
Clopidogrel Recall; COAPT Score; Pediatric Cardiologist's Child Porn
Recent developments of interest in cardiovascular medicine
Source: medpagetoday.com
Looming challenges for Europe's cell and gene therapy space
In spite of logistical obstacles from Brexit and the COVID-19 pandemic, Europe’s CGT market is catching up to that of the U.S.
Source: labiotech.eu
Global Gene Therapies For Rare Diseases Market worth $ 11.4 Billion by 2030 - Exclusive Report by InsightAce Analytic
Global Gene Therapies For Rare Diseases market is expected to reach US$ 11,441.6 Million by 2030, with a CAGR of 21.7% during a forecast period of 2022-2030.
Source: einnews.com